A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration
Clinical trial NCT04200248 · COMPLETED
Trial details
- NCT number
- NCT04200248
- Sponsor
- Ribomic USA Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-02
- Primary completion
- 2021-11-19
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.